Harvey B Dubiner

Learn More
BACKGROUND The purpose of this study was to characterize intraocular pressure (IOP) reduction throughout the day with travoprost ophthalmic solution 0.004% dosed once daily in the evening. METHODS The results of seven published, randomized clinical trials including at least one arm in which travoprost 0.004% was dosed once daily in the evening were(More)
  • 1